表紙
市場調査レポート

冠動脈血栓症:世界の臨床試験レビュー(2011年下半期)

Coronary Thrombosis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 217237
出版日 ページ情報 英文 53 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
冠動脈血栓症:世界の臨床試験レビュー(2011年下半期) Coronary Thrombosis Global Clinical Trials Review, H2, 2014
出版日: 2014年08月20日 ページ情報: 英文 53 Pages
概要

当レポートでは、冠動脈血栓症治療薬の臨床試験におけるデータを提供、国別の動向、臨床試験数、世界における臨床実験所別の募集状況などをまとめ、概略以下の構成でお届けします。

目次

イントロダクション

  • 冠動脈血栓症
  • 本レポートについて

地域別の臨床試験

  • 国別臨床試験
    • アジア太平洋における上位国
    • 欧州における上位5か国
    • 北米における上位国

G7諸国における臨床試験

進捗状況別:G7諸国における臨床試験

相別の臨床試験

進捗状況別の臨床試験

未達成の臨床試験

一定期間に採用された被験者

有望なスポンサー

有望な薬剤の比較

臨床試験プロファイル

  • 臨床試験概要:上位企業
    • Abbott Laboratories
  • 臨床試験概要:上位大学・研究所・病院
    • Scripps Health
    • Minneapolis Medical Research Foundation
    • Heart Center Bad Krozingen
    • University Hospital Gasthuisberg
    • University of Zurich
    • Samsung Medical Center
    • The University of Hong Kong
    • University Hospital Basel
    • Assistance Publique - Hopitaux de Paris

5つの主な臨床プロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2308CTIDB

GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Coronary Thrombosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Coronary Thrombosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
    • Clinical Trial Overview of Top Institutes / Government
      • Hopital de la Timone
      • Clinical Trial Overview of Hopital de la Timone
      • Fujian Provincial Hospital
      • Clinical Trial Overview of Fujian Provincial Hospital
      • Herz-Zentrum Bad Krozingen
      • Clinical Trial Overview of Herz-Zentrum Bad Krozingen
      • University of Zurich
      • Clinical Trial Overview of University of Zurich
      • NHS Greater Glasgow and Clyde
      • Clinical Trial Overview of NHS Greater Glasgow and Clyde
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
      • Odense University Hospital
      • Clinical Trial Overview of Odense University Hospital
      • Universitaire Ziekenhuizen Leuven
      • Clinical Trial Overview of Universitaire Ziekenhuizen Leuven
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital de la Timone, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fujian Provincial Hospital, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Herz-Zentrum Bad Krozingen, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • GlobalData Methodology
Back to Top